retatrutide type 2 diabetes phase 2 trial

retatrutide type 2 diabetes phase 2 trial Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, 3 Phase 2 Trial of Retatrutide

Name: retatrutide type 2 diabetes phase 2 trial Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, 3 Phase 2 Trial of Retatrutide
Brand: alexlopezconsulting.com
SKU: 919151858
Price: 22.78 USD
Availability: InStock
Rating: 4.6462 (18 reviews)

SKU: 919151858

4.6

EUR22.78 EUR66.78

Pay in 4 interest-free payments of $5.70 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 10 - Oct 15

Description

Any preparation or administration of retatrutide must occur only within an approved clinical trial, carried out by trained healthcare personnel following the trial protocol

Participants with class III obesity (BMI 40 or higher) were more likely to be late responders, meaning they needed more time to achieve significant weight loss